Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samarjit Das

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Plos One|January 16, 2020
Structure-function analyses of candidate small molecule RPN13 inhibitors with antitumor propertiesRavi K Anchoori, Marietta Tan, Ssu-Hsueh Tseng, et al.
Frontiers in Cardiovascular Medicine|January 11, 2020
Differences in microRNA-29 and Pro-fibrotic Gene Expression in Mouse and Human Hypertrophic CardiomyopathyYamin Liu, Junaid Afzal, Styliani Vakrou, et al.
Antioxidants & Redox Signaling|February 9, 2017
Exosomal MicroRNA-15a Transfer from the Pancreas Augments Diabetic Complications by Inducing Oxidative StressTengku Ain Kamalden, Anne M Macgregor-Das, Sangeetha Marimuthu Kannan, et al.
Journal of Clinical Medicine|June 27, 2024
The Impact of Silent Liver Disease on Hospital Length of Stay Following Isolated Coronary Artery Bypass Grafting SurgeryGiancarlo Suffredini, Lan Le, Seoho Lee, et al.
Plos One|September 10, 2021
Chirality and asymmetry increase the potency of candidate ADRM1/RPN13 inhibitorsRavi K Anchoori, Logan George, Ssu-Hsueh Tseng, et al.
The Journal of Clinical Investigation|August 9, 2019
Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivationW Brian Dalton, Eric Helmenstine, Noel Walsh, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Plos One|January 16, 2020
Structure-function analyses of candidate small molecule RPN13 inhibitors with antitumor propertiesRavi K Anchoori, Marietta Tan, Ssu-Hsueh Tseng, et al.
Frontiers in Cardiovascular Medicine|January 11, 2020
Differences in microRNA-29 and Pro-fibrotic Gene Expression in Mouse and Human Hypertrophic CardiomyopathyYamin Liu, Junaid Afzal, Styliani Vakrou, et al.
Antioxidants & Redox Signaling|February 9, 2017
Exosomal MicroRNA-15a Transfer from the Pancreas Augments Diabetic Complications by Inducing Oxidative StressTengku Ain Kamalden, Anne M Macgregor-Das, Sangeetha Marimuthu Kannan, et al.
Journal of Clinical Medicine|June 27, 2024
The Impact of Silent Liver Disease on Hospital Length of Stay Following Isolated Coronary Artery Bypass Grafting SurgeryGiancarlo Suffredini, Lan Le, Seoho Lee, et al.
Plos One|September 10, 2021
Chirality and asymmetry increase the potency of candidate ADRM1/RPN13 inhibitorsRavi K Anchoori, Logan George, Ssu-Hsueh Tseng, et al.
The Journal of Clinical Investigation|August 9, 2019
Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivationW Brian Dalton, Eric Helmenstine, Noel Walsh, et al.
Pageof 9